| Disease | Hepatocellular carcinoma |
| Stage of Disease/Treatment | Metastatic/advanced |
| Prior Therapy | One prior regimen |
| Type of Study | Phase II, single arm |
| Primary Endpoint | Six‐month survival rate |
| Secondary Endpoints | Disease control rate (complete response/partial response + stable disease), progression‐free survival, overall survival, AFP reduction, change in quality of life, safety |
| Investigator's Analysis | Active and should be pursued further |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.